Cervical cancer screening for women less than 21 years of age
Defines Anthem's coverage stance for cervical cancer screening (Pap test) in women younger than 21 years, specifying which clinical situations are covered (chronically immunosuppressed) and which are not; affects providers submitting claims to Anthem for members under age 21.
Cervical cancer screening is considered medically necessary for women under 21 years of age who are chronically immunosuppressed (for example, organ transplant recipients or HIV-positive individuals).
Cervical cancer screening for women less than 21 years of age is considered not medically necessary for all other indications.
Coverage Criteria
Coverage criteria
Covered when ALL of the following are met:
Document immunosuppression status (e.g., transplant history or HIV seropositivity).
Claims for cervical cancer screening procedures and testing for average‑risk women <21 will not be reimbursed effective with service dates on or after the policy effective date.
Cervical cancer screening for women <21 years of age is not covered for all indications except when the member is chronically immunosuppressed (for example, organ transplant recipients or individuals seropositive for HIV). Claims for screening in average‑risk women under 21 will not be reimbursed effective with service dates on or after the policy effective date.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.